Synovial fluid levels of anti–cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis
✍ Scribed by Caspi, Dan ;Anouk, Marina ;Golan, Itzhak ;Paran, Daphna ;Kaufman, Ilana ;Wigler, Irena ;Levartovsky, David ;Litinsky, Irena ;Elkayam, Ori
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 67 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To examine the association of treatment response and disease duration with changes in rheumatoid factor (RF) and anti–cyclic citrullinated peptide (anti‐CCP) antibody levels among patients with rheumatoid arthritis (RA). ## Methods The study sample included 66 RA patient
## Abstract ## Objective The evolution of the rheumatoid arthritis (RA)–specific anti–cyclic citrullinated peptide (anti‐CCP) antibody response, as measured by the isotypes of anti‐CCP, has not been described. This study was undertaken to determine anti‐CCP isotype usage in patients with undiffere